As of May 27, 2025, Laboratory Corporation of America Holdings (LH) reports a Current Ratio of 1.44.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Laboratory Corporation of America Holdings's Current Ratio
Over recent years, Laboratory Corporation of America Holdings's Current Ratio has shown a moderate pattern. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2024-12-31 | 1.44 |
| 2023-12-31 | 1.17 |
| 2022-12-31 | 1.50 |
| 2021-12-31 | 1.92 |
| 2020-12-31 | 1.66 |
This slight downward trend highlights how Laboratory Corporation of America Holdings manages its short-term assets and liabilities over time.
Comparing Laboratory Corporation of America Holdings's Current Ratio to Peers
To better understand Laboratory Corporation of America Holdings's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Laboratory Corporation of America Holdings (LH) | 1.44 |
| Soc Telemed Inc (TLMD) | 3.09 |
| 1Life Healthcare Inc (ONEM) | 3.03 |
| Apollo Medical Holdings Inc (AMEH) | 2.88 |
| Enzo Biochem Inc (ENZ) | 2.82 |
| Biodesix Inc (BDSX) | 2.76 |
Compared to its competitors, Laboratory Corporation of America Holdings's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.